Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App





Labs' Innovation and Leadership Will Light Up Chicago

By Karen Blum (AACC)
Posted on 12 Jul 2022
When the 2022 AACC Annual Scientific Meeting & Clinical Lab Expo kicks off this summer, it will mark the culmination of nearly 2 years of work by members of the Annual Meeting Organizing Committee (AMOC), who have been busy planning since October 2020. More...


“It's a long, intense process,” said Linnea Baudhuin, PhD, AMOC chair and professor of laboratory medicine and pathology at Mayo Clinic. “We get hundreds of session proposals and abstracts, and we go through each one carefully to ensure we’re providing well-rounded, high-quality content.”

Here, Baudhuin provides a preview of the 5-day meeting, to be held July 24-28 in Chicago.

Q: WHAT ARE YOU MOST LOOKING FORWARD TO AT THIS YEAR'S MEETING?
A: The meeting is always an inspiring, engaging event. It’s a great forum for attendees to learn from global leaders in laboratory medicine and network with colleagues. We’ll have over 250 educational opportunities in formats from lectures to interactive sessions, and roundtables to plenaries. We have an incredibly diverse group of speakers from around the world, covering all aspects of laboratory medicine and cutting-edge science.

The expo will showcase the latest technologies, including over 200 new products. We’ll have the popular Disruptive Technology competition, the Student Research and Oral Abstract awards, and the always hilarious Laboratory Feud. The meeting has so much to offer to everyone.

I'm also excited about the location. Chicago is such a fun city to visit, with great museums, a beautiful lakefront and riverfront, and amazing architecture. There’s always so much to do, especially in the summer.

HOW HAVE CHANGES IN LABORATORY MEDICINE AFFECTED THE MEETING CONTENT?
During COVID-19, laboratory medicine was a beacon of light that revealed to the world how critical our field is to healthcare. Now is the time to continue that wave of success and continue to shine through innovation and leadership.

We also need to be aware that spotlights placed on our field have led to increased interest in some legislature initiatives, including the VALID Act, which would expand the Food and Drug Administration’s power to regulate laboratory-developed tests (LDTs). It’s critically important that we understand the implications of these initiatives on our field. The “Valid Vital LDTs” expert session on Monday, July 25, is a great way to learn more about these important issues.

It's also become apparent that laboratory medicine professionals are passionate about providing optimal health care for diverse populations. We are excited this year to offer six pathways of sessions, including one on transforming population health and equity, as well as mobilizing data analytics, accelerating molecular diagnostics, and elevating point-of-care testing.

WHAT ABOUT CURRENT MEDICINE AND SCIENCE MAKES IT CRITICAL FOR US TO COLLABORATE IN THIS MANNER?
We’re living in an era of data and information. The vast amounts of data we can generate today present opportunities to make new discoveries and advance healthcare through data sharing. Connecting at the meeting can open opportunities to share data and form collaborations to make new discoveries. In that vein, several of our sessions are geared toward optimizing discoveries through data analytics and informatics.

We are also living in an era of connectivity through social media platforms. Social media can be a great tool to enhance your professional presence, connect, and discover new things about the field. I'm looking forward to our “Social Media in Laboratory Medicine” session.

With all the information thrown at us today, the meeting provides a terrific opportunity to take time to focus on our field. By enhancing our knowledge and creating connections, we can continue to elevate laboratory medicine and its importance in patient care.

WAS CAN ATTENDEES EXPECT TO TAKE AWAY FROM THIS MEETING?
I thank the 2022 AMOC for their incredible vision and hard work. We have a gamut of clinical and scientific sessions covering areas like cardiology, endocrinology, immunology, infectious disease, oncology, personalized medicine, and others. The meeting is an excellent opportunity to learn about the latest in mass spectrometry, machine learning and data analytics, translational medicine, and lab management. I encourage everyone to take advantage of all that the meeting has to offer. If you see me walking around the convention center, please say hello, and let me know what you are enjoying most about the meeting.






Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Gold Member
Automatic Hematology Analyzer
CF9600
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Blood Protein Analysis Reveals Menopause-Associated Signals of Brain Aging

Menopause affects women across midlife and is often accompanied by endocrine changes, hot flashes, brain fog and sleep disturbances. Women spend roughly one third of their lives after the menopause transition,... Read more

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

AI-Supported Approach May Improve Cervical Cancer Screening in Low-Resource Settings

Cervical cancer screening coverage often remains below 15% in low- and middle-income countries. Limited accuracy of visual inspection with acetic acid, together with uneven access to high-quality human... Read more

Hematology

view channel
Image: Mayo Clinic researchers used genetic data from nearly 50,000 participants to identify sickle cell and beta-thalassemia carrier traits, highlighting how population-scale testing can complement existing screening (Image Credit: Adobe Stock)

Genetic Testing Offers Opportunities for Earlier Blood Disorder Carrier Identification

Inherited hemoglobin disorders can affect oxygen transport, yet individuals who carry only a trait may remain unaware of their status. People with sickle cell trait or beta-thalassemia trait often have... Read more

Microbiology

view channel
Image: Four-quadrant streaking of fecal samples on chromogenic UTI agar shows various patterns of relative bacterial species abundance. The assorted shapes of the pinkish colonies indicate different E. coli strains. (Photo courtesy of Sokurenko Lab)

Stool Testing Predicts UTI Risk and Guides Antibiotic Selection

Urinary tract infections (UTIs) are a common reason for antibiotic prescribing in general medical practice and can be painful in postmenopausal women, sometimes progressing to kidney infection or life-threatening... Read more

Pathology

view channel
AI: Artificial intelligence; CNN: Convolutional neural networks; ResNet: Residual neural network. (Xing-hua Gao from The First Hospital of China Medical University, China Image Source Link: https://www.ovid.com/jnls/cmj/fulltext/10.1097/cm9.0000000000004154~deep-learning-based-computational-pathology-technologies)

Review Highlights Progress and Validation Needs for AI in Digital Pathology

Pathology remains the gold standard for disease diagnosis, but clinical laboratories face growing demands for faster, more reproducible diagnostic and prognostic workflows. Digital pathology based on whole-slide... Read more

Industry

view channel
Image: SG-INSIGHT study will extend whole- genome sequencing to nearly 1 in 10 Singapore residents, generating evidence to inform how precision medicine could be implemented in Singapore’s healthcare system. (Photo courtesy of Precision Health Research, Singapore)

Illumina Selected to Support National Genomics Study for Personalized Healthcare in Singapore

Singapore’s National Precision Medicine program is using genomic and health data to support more preventive and personalized healthcare. Its latest phase expands beyond healthy volunteers to people with... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.